Options Brief: Becton, Dickinson and Company (BDX)

Shares of Becton, Dickinson and Company BDX are higher on the session by 0.51%, trading at $80.80. Overall call volume is now running at 4.16x the daily average, with 100% of all calls traded being purchases on the offer. 1,032 contracts have traded on the session so far. Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.